异动解读2025-11-04
远程医疗公司Hims & Hers Health（HIMS）周一夜盘大涨5.45%，主要受益于公司发布的第三季度财报显示业绩超出市场预期。
根据公司公布的财报，Hims & Hers Health第三季度实现营收6亿美元，超过分析师预期的5.802亿美元，同比增长49%。公司用户数增至247万，同比增长21%，平均每位用户的月在线收入攀升19%，达到80美元。这些数据都显示出公司业务的强劲增长态势。此外，公司2025年第三季度调整后EBITDA为7840万美元，较去年同期的5110万美元有显著增长。
值得注意的是，Hims & Hers Health正在与诺和诺德积极洽谈，以便通过其平台提供Wegovy注射剂和口服Wegovy。这一潜在合作可能进一步扩大公司的业务范围，为未来增长提供新的动力。公司首席执行官安德鲁·杜杜姆表示，公司正在加速实现2030年65亿美元的收入目标，依靠对诊断供应商的投资、自身实验室检测基础设施的发展、更年期和激素治疗以及国际扩张。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
